GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (SHSE:688331) » Definitions » Total Inventories

RemeGen Co (SHSE:688331) Total Inventories : ¥741 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RemeGen Co Total Inventories?

RemeGen Co's total inventories for the quarter that ended in Jun. 2024 was ¥741 Mil. RemeGen Co's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Jun. 2024 was ¥741 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. RemeGen Co's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was ¥-2.96.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. RemeGen Co's Days Inventory for the six months ended in Jun. 2024 was 799.02.

Inventory Turnover measures how fast the company turns over its inventory within a year. RemeGen Co's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.23.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. RemeGen Co's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 1.00.


RemeGen Co Total Inventories Historical Data

The historical data trend for RemeGen Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co Total Inventories Chart

RemeGen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Inventories
Get a 7-Day Free Trial 31.25 66.20 280.31 522.67 741.56

RemeGen Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 362.42 522.67 708.47 741.56 740.65

RemeGen Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


RemeGen Co  (SHSE:688331) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

RemeGen Co's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is

Net-Net Working Capital Per Share (Q: Jun. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(877.017+0.75 * 307.924+0.5 * 740.65-3089.927
-0-0)/544.263
=-2.96

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

RemeGen Co's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2024 )/Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=741.105/169.271*365 / 2
=799.02

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

RemeGen Co's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2024 ) / Average Total Inventories (Q: Jun. 2024 )
=169.271 / 741.105
=0.23

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

RemeGen Co's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=741.105 / 739.656
=1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


RemeGen Co Total Inventories Related Terms

Thank you for viewing the detailed overview of RemeGen Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


RemeGen Co Business Description

Traded in Other Exchanges
Address
58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.

RemeGen Co Headlines

No Headlines